» Articles » PMID: 34194879

Myxedema Coma: Case Report and Literature Review

Overview
Journal Cureus
Date 2021 Jul 1
PMID 34194879
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Myxedema coma is a life-threatening manifestation of hypothyroidism associated with altered mental status, hypothermia, and symptoms related to the slowing of other organ systems. It can occur as a culmination of severe, longstanding hypothyroidism or be precipitated by acute stressors such as infection, myocardial infarction, cold exposure, and surgery in patients with poorly controlled hypothyroidism. Given the high mortality rate and acuity with which the disease presents, treatment with thyroid hormone replacement should be initiated upon suspicion of the disease even prior to obtaining laboratory confirmation. Stress doses of hydrocortisone should also be given until coexisting adrenal insufficiency is excluded. We present a case of a 58-year-old male who presented to the emergency department after being found on the floor of his house. Physical examinations and laboratory results were significant for myxedema coma and the patient was given levothyroxine with improvement of symptoms and mild change in thyroid hormone levels during hospitalization.

Citing Articles

Distributive and Refractory Shock in Myxoedema Coma.

Macedo C, Costa M, Eira I, Castro R, Silveira P Cureus. 2025; 16(12):e75366.

PMID: 39781122 PMC: 11707966. DOI: 10.7759/cureus.75366.


Myxedema Coma Precipitated by Sepsis in a Patient With a Complex Mental Health History.

Amin M, Pabani U, Lohano S, Khan Z Cureus. 2023; 15(8):e43574.

PMID: 37719600 PMC: 10503452. DOI: 10.7759/cureus.43574.


Amiodarone-Induced Myxedema Coma in Elderly Patients: A Systematic Review of Case Reports.

Alnaeem M, Suleiman K, Mansour N, Alwahsh B, Nashwan A Cureus. 2023; 15(6):e40893.

PMID: 37492810 PMC: 10364664. DOI: 10.7759/cureus.40893.


Surprising Diagnosis of Myxedema Crisis In-Patient Who Presented With Altered Sensorium.

Umalkar G, Chavan G, Gadkari C, Wanjari M Cureus. 2023; 15(1):e33743.

PMID: 36788845 PMC: 9922525. DOI: 10.7759/cureus.33743.


Acute thyroid swelling with severe hypothyroid myxoedema after COVID-19 vaccination.

Giusti M, Maio A Clin Case Rep. 2021; 9(12):e05217.

PMID: 34938565 PMC: 8667292. DOI: 10.1002/ccr3.5217.

References
1.
Rodriguez I, Fluiters E, Perez-Mendez L, Luna R, Paramo C, Garcia-Mayor R . Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004; 180(2):347-50. DOI: 10.1677/joe.0.1800347. View

2.
Wall C . Myxedema coma: diagnosis and treatment. Am Fam Physician. 2000; 62(11):2485-90. View

3.
Kwaku M, Burman K . Myxedema coma. J Intensive Care Med. 2007; 22(4):224-31. DOI: 10.1177/0885066607301361. View

4.
Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y . Clinical characteristics and outcomes of myxedema coma: Analysis of a national inpatient database in Japan. J Epidemiol. 2017; 27(3):117-122. PMC: 5350620. DOI: 10.1016/j.je.2016.04.002. View

5.
Biondi B, Wartofsky L . Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism?. J Clin Endocrinol Metab. 2012; 97(7):2256-71. DOI: 10.1210/jc.2011-3399. View